"Designing Growth Strategies is in our DNA"

U.S. Allergic Conjunctivitis Market Size, Share & Industry Analysis, By Drug Class (Antihistamines & Mast Cell Stabilizers, Corticosteroids, and Others), By Disease Type (Severe Allergic Conjunctivitis and Mild Allergic Conjunctivitis), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies), and Country Forecast, 2024-2032

Last Updated: March 10, 2025 | Format: PDF | Report ID: FBI108497

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Allergic Conjunctivitis, 2023
    2. Pipeline Analysis, By Key Players
    3. Key Industry Developments, By Key Players
    4. New Product Launches, By Key Players
    5. Impact of COVID 19 on the Market
  5. U.S. Allergic Conjunctivitis Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Antihistamines & Mast Cell Stabilizers
      2. Corticosteroids
      3. Others 
    2. Market Analysis, Insights and Forecast – By Disease Type
      1. Mild Allergic Conjunctivitis
      2. Severe Allergic Conjunctivitis 
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies 
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2023)
    2. Company Profiles
      1. Teva Pharmaceutical Industries Ltd.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. AbbVie Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. Alcon Inc. (Novartis AG)
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Bausch + Lomb
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. Sun Pharmaceutical Industries Ltd.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Harrow, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. Ocular Therapeutix, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
Read Less

Figure 1: U.S. Allergic Conjunctivitis Market Revenue Breakdown (USD billion, %) by Drug Class, 2023 & 2032

Figure 2: U.S. Allergic Conjunctivitis Market Value Share (%), by Drug Class, 2023 & 2032

Figure 3: U.S. Allergic Conjunctivitis Market Value Share (%), by Disease Type, 2023 & 2032

Figure 4: U.S. Allergic Conjunctivitis Market Value Share (%), by Distribution Channel, 2023 & 2032

Figure 5: U.S. Allergic Conjunctivitis Market Share (%), By Company, 2023

Table 1: U.S. Allergic Conjunctivitis Market Revenue (USD billion) Forecast, by Drug Class, 2019–2032

Table 2: U.S. Allergic Conjunctivitis Market Revenue (USD billion) Forecast, by Disease Type, 2019–2032

Table 3: U.S. Allergic Conjunctivitis Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

U.S. Allergic Conjunctivitis Market Size, Share and Global Industry Trend Forecast till 2032
  • 2019-2032
  • 2023
  • 2019-2022
  • 85
Consulting Services
    How will you benefit from our consulting services ?